Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Antiandrogen therapy helps treat genetic hair loss.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Neurosteroids help control dopamine responses in the brain.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Certain chemicals and peptides can promote hair growth or prevent baldness.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Muscles can make their own androgens, which may help muscle growth.

Enzymatic synthesis improved the water solubility of the flavonoid baicalin, which may help treat hair loss conditions.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Clascoterone may be an effective topical treatment for hair loss.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.